Right ventricular afterload and the role of nitric oxide metabolism in left-sided heart failure

Journal of Cardiac Failure

Volumn 19, Issue 10, 2013, Pages 712-721

  Dupont, Matthias ^a   Tang, W H Wilson ^b  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Nitric oxide; pulmonary arterial compliance; pulmonary vascular resistance; right ventricular afterload

Indexed keywords

ANGIOTENSIN II; CYCLIC GMP; ENDOTHELIN 1; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTACYCLIN RECEPTOR;

ARTERY COMPLIANCE; ARTICLE; ENZYME METABOLISM; EXERCISE; FLOW MEASUREMENT; HEART AFTERLOAD; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HEART VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HUMAN; IMPEDANCE; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG CIRCULATION; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; QUALITY OF LIFE; RIGHT VENTRICULAR AFTERLOAD; SYMPATHETIC TONE; WALL STRESS;

NITRIC OXIDE; PULMONARY ARTERIAL COMPLIANCE; PULMONARY VASCULAR RESISTANCE; RIGHT VENTRICULAR AFTERLOAD;

ANIMALS; HEART FAILURE; HUMANS; NITRIC OXIDE; PULMONARY WEDGE PRESSURE; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84885936753     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.08.004     Document Type: Review

References (97)

1. J.F. Polak, B.L. Holman, J. Wynne, and W.S. Colucci Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease J Am Coll Cardiol 2 1983 217 224
2. S. Ghio, A. Gavazzi, C. Campana, C. Inserra, C. Klersy, and R. Sebastiani Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188
3. Y. Juilliere, G. Barbier, L. Feldmann, A. Grentzinger, N. Danchin, and F. Cherrier Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy Eur Heart J 18 1997 276 280
4. P. de Groote, A. Millaire, C. Foucher-Hossein, O. Nugue, X. Marchandise, and G. Ducloux Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure J Am Coll Cardiol 32 1998 948 954
5. T.G. di Salvo, M. Mathier, M.J. Semigran, and G.W. Dec Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure J Am Coll Cardiol 25 1995 1143 1153
6. B.J. Baker, M.M. Wilen, C.M. Boyd, H. Dinh, and J.A. Franciosa Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure Am J Cardiol 54 1984 596 599
7. W. Mullens, Z. Abrahams, G.S. Francis, G. Sokos, D.O. Taylor, and R.C. Starling Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
8. M. Dupont, W. Mullens, and W.H. Tang Impact of systemic venous congestion in heart failure Curr Heart Fail Rep 8 2011 233 241
9. F.L. Abel, and J.A. Waldhausen Effects of alterations in pulmonary vascular resistance on right ventricular function J Thorac Cardiovasc Surg 54 1967 886 894
10. R.P. Kondo, D.A. Dederko, C. Teutsch, J. Chrast, D. Catalucci, and K.R. Chien Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform J Physiol 571 2006 131 146
11. J.M. Norton Toward consistent definitions for preload and afterload Adv Physiol Educ 25 2001 53 61
12. W.R. Milnor Arterial impedance as ventricular afterload Circ Res 36 1975 565 570
13. N. Saouti, N. Westerhof, P.E. Postmus, and A. Vonk-Noordegraaf The arterial load in pulmonary hypertension Eur Respir Rev 19 2010 197 203
14. W.R. Milnor Pulsatile blood flow N Engl J Med 287 1972 27 34
15. J.A. Chirinos, and P. Segers Noninvasive evaluation of left ventricular afterload: part 1: pressure and flow measurements and basic principles of wave conduction and reflection Hypertension 56 2010 555 562
16. J.A. Chirinos, and P. Segers Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans Hypertension 56 2010 563 570
17. O. F Die grundform des arteriellen pulses Zeitschr Biol 37 1899 483 526
18. N. Stergiopulos, J.J. Meister, and N. Westerhof Evaluation of methods for estimation of total arterial compliance Am J Physiol 268 1995 H1540 H1548
19. D. Chemla, J.L. Hebert, C. Coirault, K. Zamani, I. Suard, and P. Colin Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans Am J Physiol 274 1998 H500 H505
20. E. Wetterer Flow and pressure in the arterial system, their hemodynamic relationship, and the principles of their measurement Minn Med 37 1954 77 86
21. N. Westerhof, G. Elzinga, and P. Sipkema An artificial arterial system for pumping hearts J Appl Physiol 31 1971 776 781
22. K. Sunagawa, W.L. Maughan, D. Burkhoff, and K. Sagawa Left ventricular interaction with arterial load studied in isolated canine ventricle Am J Physiol 245 1983 H773 H780
23. R.P. Kelly, C.T. Ting, T.M. Yang, C.P. Liu, W.L. Maughan, and M.S. Chang Effective arterial elastance as index of arterial vascular load in humans Circulation 86 1992 513 521
24. P. Morimont, B. Lambermont, A. Ghuysen, P. Gerard, P. Kolh, and P. Lancellotti Effective arterial elastance as an index of pulmonary vascular load Am J Physiol Heart Circ Physiol 294 2008 H2736 H2742
25. D.A. Kass, and R.P. Kelly Ventriculo-arterial coupling: concepts, assumptions, and applications Ann Biomed Eng 20 1992 41 62
26. B.A. Borlaug, and D.A. Kass Ventricular-vascular interaction in heart failure Heart Fail Clin 4 2008 23 36
27. P.D. Chantler, E.G. Lakatta, and S.S. Najjar Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise J Appl Physiol 105 2008 1342 1351
28. K. Horsfield Morphometry of the small pulmonary arteries in man Circ Res 42 1978 593 597
29. N. Saouti, N. Westerhof, F. Helderman, J.T. Marcus, N. Stergiopulos, and B.E. Westerhof RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension Am J Physiol Heart Circ Physiol 297 2009 H2154 H2160
30. J.W. Lankhaar, N. Westerhof, T.J. Faes, K.M. Marques, J.T. Marcus, and P.E. Postmus Quantification of right ventricular afterload in patients with and without pulmonary hypertension Am J Physiol Heart Circ Physiol 291 2006 H1731 H1737
31. J.W. Lankhaar, N. Westerhof, T.J. Faes, C.T. Gan, K.M. Marques, and A. Boonstra Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension Eur Heart J 29 2008 1688 1695
32. D. Bonderman, A.M. Martischnig, K. Vonbank, M. Nikfardjam, B. Meyer, and G. Heinz Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy Chest 139 2011 122 127
33. R.J. Tedford, P.M. Hassoun, S.C. Mathai, R.E. Girgis, S.D. Russell, and D.R. Thiemann Pulmonary capillary wedge pressure augments right ventricular pulsatile loading Circulation 125 2012 289 297
34. M. Dupont, W. Mullens, H.N. Skouri, Z. Abrahams, Y. Wu, and D.O. Taylor Prognostic role of pulmonary arterial capacitance in advanced heart failure Circ Heart Fail 5 2012 778 785
35. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, and C.P. Denton Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
36. G. Kovacs, A. Berghold, S. Scheidl, and H. Olschewski Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review Eur Respir J 34 2009 888 894
37. J. Butler, D.B. Chomsky, and J.R. Wilson Pulmonary hypertension and exercise intolerance in patients with heart failure J Am Coll Cardiol 34 1999 1802 1806
38. S. Schwartzenberg, M.M. Redfield, A.M. From, P. Sorajja, R.A. Nishimura, and B.A. Borlaug Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy J Am Coll Cardiol 59 2012 442 451
39. D. Aronson, A. Eitan, R. Dragu, and A.J. Burger Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure Circ Heart Fail 4 2011 644 650
40. M. Guazzi, and B.A. Borlaug Pulmonary hypertension due to left heart disease Circulation 126 2012 975 990
41. J.B. West, and O. Mathieu-Costello Vulnerability of pulmonary capillaries in heart disease Circulation 92 1995 622 631
42. J.F. Delgado, E. Conde, V. Sanchez, F. Lopez-Rios, M.A. Gomez-Sanchez, and P. Escribano Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure Eur J Heart Fail 7 2005 1011 1016
43. M. Rabinovitch EVE and beyond, retro and prospective insights Am J Physiol 277 1999 L5 12
44. B. Stobierska-Dzierzek, H. Awad, and R.E. Michler The evolving management of acute right-sided heart failure in cardiac transplant recipients J Am Coll Cardiol 38 2001 923 931
45. R. Naeije, and N. Chesler Pulmonary circulation at exercise Compr Physiol 2 2012 711 741
46. J.T. Reeves, J.H. Linehan, and K.R. Stenmark Distensibility of the normal human lung circulation during exercise Am J Physiol Lung Cell Mol Physiol 288 2005 L419 L425
47. J.T. Reeves, R.E. Moon, R.F. Grover, and B.M. Groves Increased wedge pressure facilitates decreased lung vascular resistance during upright exercise Chest 93 1988 97S 99S
48. G.D. Lewis, R.M. Murphy, R.V. Shah, P.P. Pappagianopoulos, R. Malhotra, and K.D. Bloch Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes Circ Heart Fail 4 2011 276 285
49. J.J. Tolle, A.B. Waxman, T.L. Van Horn, P.P. Pappagianopoulos, and D.M. Systrom Exercise-induced pulmonary arterial hypertension Circulation 118 2008 2183 2189
50. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, and M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ Heart Fail 3 2010 588 595
51. A. Benetos, M. Safar, A. Rudnichi, H. Smulyan, J.L. Richard, and P. Ducimetieere Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population Hypertension 30 1997 1410 1415
52. G.F. Mitchell, L.A. Moye, E. Braunwald, J.L. Rouleau, V. Bernstein, E.M. Geltman SAVE Investigators Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Survival and Ventricular Enlargement Circulation 96 1997 4254 4260
53. M.J. Domanski, G.F. Mitchell, J.E. Norman, D.V. Exner, B. Pitt, and M.A. Pfeffer Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction J Am Coll Cardiol 33 1999 951 958
54. S. Mahapatra, R.A. Nishimura, P. Sorajja, S. Cha, and M.D. McGoon Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension J Am Coll Cardiol 47 2006 799 803
55. D.L. Moraes, W.S. Colucci, and M.M. Givertz Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management Circulation 102 2000 1718 1723
56. R.F. Furchgott The role of endothelium in the responses of vascular smooth muscle to drugs Annu Rev Pharmacol Toxicol 24 1984 175 197
57. L.J. Ignarro, G.M. Buga, K.S. Wood, R.E. Byrns, and G. Chaudhuri Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc Natl Acad Sci U S A 84 1987 9265 9269
58. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
59. F.H. Guo, H.R. de Raeve, T.W. Rice, D.J. Stuehr, F.B. Thunnissen, and S.C. Erzurum Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo Proc Natl Acad Sci U S A 92 1995 7809 7813
60. B. Greenberg, K. Rhoden, and P.J. Barnes Endothelium-dependent relaxation of human pulmonary arteries Am J Physiol 252 1987 H434 H438
61. J.S. Stamler, E. Loh, M.A. Roddy, K.E. Currie, and M.A. Creager Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans Circulation 89 1994 2035 2040
62. C.J. Cooper, M.J. Landzberg, T.J. Anderson, F. Charbonneau, M.A. Creager, and P. Ganz Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans Circulation 93 1996 266 271
63. C.J. Cooper, F.W. Jevnikar, T. Walsh, J. Dickinson, A. Mouhaffel, and A.P. Selwyn The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure Am J Cardiol 82 1998 609 614
64. F. Habib, D. Dutka, D. Crossman, C.M. Oakley, and J.G. Cleland Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 344 1994 371 373
65. M. Usui, H. Matsuoka, H. Miyazaki, S. Ueda, S. Okuda, and T. Imaizumi Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure Life Sci 62 1998 2425 2430
66. S. Pullamsetti, L. Kiss, H.A. Ghofrani, R. Voswinckel, P. Haredza, and W. Klepetko Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension FASEB J 19 2005 1175 1177
67. W.H. Tang, Z. Wang, L. Cho, D.M. Brennan, and S.L. Hazen Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk J Am Coll Cardiol 53 2009 2061 2067
68. Z. Wang, W.H. Tang, L. Cho, D.M. Brennan, and S.L. Hazen Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition Arterioscler Thromb Vasc Biol 29 2009 1383 1391
69. M. Saitoh, T. Osanai, T. Kamada, T. Matsunaga, H. Ishizaka, and H. Hanada High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level Heart Vessels 18 2003 177 182
70. Z. Shao, Z. Wang, K. Shrestha, A. Thakur, A.G. Borowski, and W. Sweet Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1 J Am Coll Cardiol 59 2012 1150 1158
71. American Thoracic Society, European Respiratory Society ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 Am J Respir Crit Care Med 171 2005 912 930
72. E. Clini, M. Volterrani, M. Pagani, L. Bianchi, R. Porta, and L.S. Gile Endogenous nitric oxide in patients with chronic heart failure (CHF): relation to functional impairment and nitrate-containing therapies Int J Cardiol 73 2000 123 130 discussion 31-4
73. P. Agostoni, and M. Bussotti Exhaled nitric oxide and exercise performance in heart failure Arch Physiol Biochem 111 2003 293 296
74. J.M. Hare, G.C. Nguyen, A.F. Massaro, J.M. Drazen, L.W. Stevenson, and W.S. Colucci Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure J Am Coll Cardiol 40 2002 1114 1119
75. A. Schuster, A. Thakur, Z. Wang, A.G. Borowski, J.D. Thomas, and W.H. Tang Increased exhaled nitric oxide levels after exercise in patients with chronic systolic heart failure with pulmonary venous hypertension J Card Fail 18 2012 799 803
76. N. Seshadri, R.A. Dweik, D. Laskowski, C. Pothier, L. Rodriguez, and J.B. Young Dysregulation of endogenous carbon monoxide and nitric oxide production in patients with advanced ischemic or nonischemic cardiomyopathy Am J Cardiol 92 2003 820 823
77. A.R. Tonelli, S. Haserodt, M. Aytekin, and R.A. Dweik Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy Pulm Circ 3 2013 20 30
78. 2) kinetics during exercise in patients with chronic heart failure Jpn Circ J 63 1999 255 260
79. M. Bussotti, D. Andreini, and P. Agostoni Exercise-induced changes in exhaled nitric oxide in heart failure Eur J Heart Fail 6 2004 551 554
80. S.D. Katz, K. Hryniewicz, I. Hriljac, K. Balidemaj, C. Dimayuga, and A. Hudaihed Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure Circulation 111 2005 310 314
81. D.J. van Veldhuisen, F. Braunschweig, V. Conraads, I. Ford, M.R. Cowie, and G. Jondeau Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure Circulation 124 2011 1719 1726
82. R.C. Bourge, W.T. Abraham, P.B. Adamson, M.F. Aaron, J.M. Aranda Jr., and A. Magalski Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study J Am Coll Cardiol 51 2008 1073 1079
83. W.T. Abraham, P.B. Adamson, R.C. Bourge, M.F. Aaron, M.R. Costanzo, and L.W. Stevenson Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
84. J. Ritzema, R. Troughton, I. Melton, I. Crozier, R. Doughty, and H. Krum Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure Circulation 121 2010 1086 1095
85. M. Guazzi, G. Tumminello, F. di Marco, and M.D. Guazzi Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure Clin Pharmacol Ther 76 2004 371 378
86. J.J. Lepore, A. Maroo, L.M. Bigatello, G.W. Dec, W.M. Zapol, and K.D. Bloch Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide Chest 127 2005 1647 1653
87. G.D. Lewis, R. Shah, K. Shahzad, J.M. Camuso, P.P. Pappagianopoulos, and J. Hung Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension Circulation 116 2007 1555 1562
88. M. Argenziano, A.F. Choudhri, N. Moazami, E.A. Rose, C.R. Smith, and H.R. Levin Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension Ann Thorac Surg 65 1998 340 345
89. N. Kieler-Jensen, S. Lundin, and S.E. Ricksten Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside J Heart Lung Transplant 14 1995 436 443
90. A. Behling, L.E. Rohde, F.C. Colombo, L.A. Goldraich, R. Stein, and N. Clausell Effects of 5′-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial J Card Fail 14 2008 189 197
91. M. Guazzi, M. Vicenzi, R. Arena, and M.D. Guazzi PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study Circ Heart Fail 4 2011 8 17
92. M. Guazzi, M. Vicenzi, R. Arena, and M.D. Guazzi Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study Circulation 124 2011 164 174
93. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, and G. Lewis Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 2013 1 10
94. I. Anand, J. McMurray, J.N. Cohn, M.A. Konstam, T. Notter, and K. Quitzau Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin-A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 347 354
95. J.J. McMurray, J.R. Teerlink, G. Cotter, R.C. Bourge, J.G. Cleland, and G. Jondeau Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2007 2009 2019
96. R.M. Califf, K.F. Adams, W.J. McKenna, M. Gheorghiade, B.F. Uretsky, and S.E. McNulty A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST) Am Heart J 134 1997 44 54
97. N. Westerhof, J.W. Lankhaar, and B.E. Westerhof The arterial windkessel Med Biol Eng Comput 47 2009 131 141